Catherine A McCall

Title: The Innovations of Catherine A McCall

Introduction

Catherine A McCall is a prominent inventor based in Boulder, CO (US). She has made significant contributions to the field of biotechnology, holding a total of 16 patents. Her work primarily focuses on the development of therapeutic and diagnostic reagents, particularly in relation to immunology.

Latest Patents

Among her latest patents is the invention titled "Dermatophagoides nucleic acid molecules." This invention relates to high molecular weight proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from these proteins. Another notable patent is "Feline immunoglobulin E molecules and related methods." This invention encompasses nucleic acid molecules encoding the light and heavy chains of feline immunoglobulin E (IgE), including species-specific regions of feline IgE. It also covers proteins encoded by these nucleic acid molecules, inhibitors to the nucleic acids and proteins, antibodies to the proteins, and methods for treating IgE-mediated responses, such as allergies.

Career Highlights

Catherine A McCall is currently associated with Heska Corporation, where she continues to innovate and contribute to advancements in veterinary medicine and immunology. Her extensive research and development efforts have positioned her as a key figure in her field.

Collaborations

Catherine has collaborated with notable colleagues, including Eric R Weber and Shirley Wu Hunter. These collaborations have further enhanced her research and the impact of her inventions.

Conclusion

Catherine A McCall's work exemplifies the intersection of innovation and biotechnology. Her patents and contributions to the field of immunology demonstrate her commitment to advancing medical science. Her ongoing efforts at Heska Corporation continue to pave the way for new therapeutic solutions.